- Home
- CWK vs ALVO Comparison
CWK vs ALVO Comparison
Compare CWK & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CWK
- ALVO
- Stock Information
- Founded
- CWK 1784
- ALVO 2013
- Country
- CWK United States
- ALVO Luxembourg
- Employees
- CWK N/A
- ALVO N/A
- Industry
- CWK Real Estate
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- CWK Finance
- ALVO Health Care
- Exchange
- CWK Nasdaq
- ALVO Nasdaq
- Market Cap
- CWK 2.7B
- ALVO 2.5B
- IPO Year
- CWK 2018
- ALVO N/A
- Fundamental
- Price
- CWK $11.93
- ALVO $8.79
- Analyst Decision
- CWK Hold
- ALVO
- Analyst Count
- CWK 8
- ALVO 0
- Target Price
- CWK $13.63
- ALVO N/A
- AVG Volume (30 Days)
- CWK 2.1M
- ALVO 338.2K
- Earning Date
- CWK 08-05-2025
- ALVO 08-14-2025
- Dividend Yield
- CWK N/A
- ALVO N/A
- EPS Growth
- CWK 1337.16
- ALVO N/A
- EPS
- CWK 0.69
- ALVO 0.34
- Revenue
- CWK $9,546,300,000.00
- ALVO $587,890,000.00
- Revenue This Year
- CWK $5.56
- ALVO $36.67
- Revenue Next Year
- CWK $5.66
- ALVO $42.58
- P/E Ratio
- CWK $17.57
- ALVO $25.93
- Revenue Growth
- CWK 1.24
- ALVO 413.92
- 52 Week Low
- CWK $7.64
- ALVO $7.35
- 52 Week High
- CWK $16.11
- ALVO $13.70
- Technical
- Relative Strength Index (RSI)
- CWK 57.57
- ALVO 43.64
- Support Level
- CWK $11.58
- ALVO $8.51
- Resistance Level
- CWK $12.68
- ALVO $9.94
- Average True Range (ATR)
- CWK 0.34
- ALVO 0.40
- MACD
- CWK 0.02
- ALVO 0.05
- Stochastic Oscillator
- CWK 56.61
- ALVO 28.57
About CWK Cushman & Wakefield plc
Cushman & Wakefield is one of the largest commercial real estate services firms in the world, with global headquarters in Chicago. The firm provides various real estate-related services to owners, occupiers, and investors. These include brokerage services for leasing and capital markets sales as well as advisory services such valuation, project management, and facilities management.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.